Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Menziani

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry|August 1, 1996
Molecular structure and dynamics of some potent 5-HT3 receptor antagonists. Insight into the interaction with the receptorA Cappelli, A Donati, M Anzini, et al.
Journal of Medicinal Chemistry|February 13, 1999
Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonistsA Leonardi, G Motta, C Boi, et al.
Journal of Medicinal Chemistry|August 29, 1997
Mapping the peripheral benzodiazepine receptor binding site by conformationally restrained derivatives of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide (PK11195)A Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|February 16, 1996
Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptorsA Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|April 21, 2001
Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modelingM Anzini, A Cappelli, S Vomero, et al.
Journal of Biomaterials Applications|July 12, 2007
Properties of zinc releasing surfaces for clinical applicationsG Lusvardi, G Malavasi, L Menabue, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|May 7, 1999
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptorsA Cappelli, M Anzini, S Vomero, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry|August 1, 1996
Molecular structure and dynamics of some potent 5-HT3 receptor antagonists. Insight into the interaction with the receptorA Cappelli, A Donati, M Anzini, et al.
Journal of Medicinal Chemistry|February 13, 1999
Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonistsA Leonardi, G Motta, C Boi, et al.
Journal of Medicinal Chemistry|August 29, 1997
Mapping the peripheral benzodiazepine receptor binding site by conformationally restrained derivatives of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide (PK11195)A Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|February 16, 1996
Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptorsA Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|April 21, 2001
Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modelingM Anzini, A Cappelli, S Vomero, et al.
Journal of Biomaterials Applications|July 12, 2007
Properties of zinc releasing surfaces for clinical applicationsG Lusvardi, G Malavasi, L Menabue, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Journal of Medicinal Chemistry|May 7, 1999
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptorsA Cappelli, M Anzini, S Vomero, et al.
Pageof 3